NCM, NST EVN, PRU: Take a look at these ASX gold stocks' performance
According to Newcrest's operating report, the business met its gold production forecast for FY22 satisfactorily. However, the company's copper production declined by 3% as compared to the guidance for FY22.
- August 08, 2022 07:00 PM AEST
- Bhawna Gupta
Sayona (ASX:SYA) closes 16% strong today, here’s why
Sayona recently entered into an agreement with Acuity Capital to renew its At-the-Market subscription. The new At-the-Market agreement is now valid up to 31 July 2025, and the facility limit has been increased to AU$200 million.
- August 08, 2022 06:08 PM AEST
- Ritwika
Why is Perpetual Protocol (PERP) crypto dipping today?
The PERP crypto on 8 August witnessed a loss of 1.65% at 6:00 AM (GMT +1) and a volume loss of over 30%, according to CoinMarketCap
- August 08, 2022 05:56 PM AEST
- Manu Shankar
What made Anova Metals (ASX:AWV) close 50% strong today?
Shares of ANOVA Metals Limited (ASX:AWV) surged by 50% on the ASX today despite no price sensitive announcement.
- August 08, 2022 05:25 PM AEST
- Sonal Goyal
ASX 200 closes marginally up; energy, materials sectors lead gains
• The ASX 200 benchmark index closed up today, increased 0.071% to end at 7,020.60 points.
- August 08, 2022 04:33 PM AEST
- Bhawna Gupta
From FRX to TLS, MAQ: How are these telecom stocks faring on ASX?
Flexiroam, Hubify, Tuas, Telstra, etc. are some of the top ASX-listed telecom stocks.
- August 08, 2022 04:21 PM AEST
- Aditi Sarkar
Neuren (ASX:NEU) initiates Phase 2 trials of NNZ-2591
Neuren Pharmaceuticals (ASX:NEU) has started enrolment for Phase 2 clinical trials of its second drug candidate, NNZ-2591 in PMS and PTHS.
- August 08, 2022 04:19 PM AEST
- Aditi Sarkar
Here’s why Mesoblast (ASX:MSB) has suspended trading today
Mesoblast shares went under a voluntary suspension on the ASX today. Trading is expected to commence after the company releases its capital raising announcement on 10 August 2022.
- August 08, 2022 03:59 PM AEST
- Ritwika
Imugene (ASX:IMU) Presents New PD1-Vaxx Data at 2022 WCLC
Highlights,Imugene Limited (ASX:IMU) has presented new data from non-small cell lung cancer patients in the Phase I IMPRINTER study at the IASLC 2022 World Conference on Lung Cancer.,The IMPRINTER trial is an ongoing open-label dose escalation study of IM...
- August 08, 2022 03:03 PM AEST
- Manisha
Here's how much Sandfire Resources (ASX:SFR) has gained in a month
Shares of Sandfire Resources (ASX:SFR) are gaining on the ASX today though the company has not shared nay price-sensitive news.
- August 08, 2022 02:36 PM AEST
- Sonal Goyal